Back to Results
First PageMeta Content
Immunology / Biotechnology / Immune system / Autoimmune diseases / Monoclonal antibodies / TNF inhibitor / Ulcerative colitis / Biologic / Infliximab / Medicine / Anatomy / Health


AVX-470, an Orally Delivered Anti-TNF Antibody for Treatment of Acute Ulcerative Colitis: Results of a First-inHuman Trial M Scott Harris1, Deborah Hartman1, Sharon Spence1, Sally Kennedy1, Theodore Ptak2, Ronald Pruitt3
Add to Reading List

Document Date: 2014-10-22 17:54:16

Open Document

File Size: 421,92 KB

Share Result on Facebook

City

Toronto / Lexington / Leuven / Nashville / /

Company

Theravance / Toronto Digestive Disease Associates / /

Country

Belgium / United States / Canada / /

Facility

University Hospital Gasthuisberg / Nashville Medical Research Institute / /

IndustryTerm

dairy products / whey-based food additives / /

MedicalCondition

disease / inflammation / Acute Ulcerative Colitis / /

MedicalTreatment

immunosuppression / /

Organization

Nashville Medical Research Institute / /

Product

prednisone / /

Technology

Pharmacokinetics / Pharmacodynamics / Antibodies / /

SocialTag